Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Travere Therapeutics is a US-based biopharmaceutical company dedicated to the development of innovative therapies for rare kidney diseases. Through cutting-edge research, the company identifies and delivers life-changing solutions to patients worldwide, addressing significant unmet medical needs.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Travere Therapeutics is scheduled to report its next quarterly earnings on 10/22/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Travere Therapeutics last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.37 USD.
Across its last 3 earnings reports, Travere Therapeutics stock moved by ±5.3% on average the following day. The largest reaction was +12% on 08/04/2026; 2 of 3 reactions were positive.
Travere Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.